Long-term Safety and Efficacy Study of Octreotide Implant in Patients With Acromegaly

This study has been terminated.
(Program was terminated for business reasons)
Sponsor:
Information provided by (Responsible Party):
Endo Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT01295060
First received: February 10, 2011
Last updated: September 17, 2013
Last verified: September 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2012
  Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: September 9, 2013